SCHEMBL6763008

SCHEMBL6763008

COc1ccc(NC(=O)Nc2ccccc2)c(O)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR2 P25025 3/20 0.67
TP53 P04637 1/20 0.60
TSHR P16473 1/20 0.60
CXCR1 P25024 2/20 0.58
MAPT P10636 5/20 0.57
RAB9A P51151 5/20 0.57
NPC1 O15118 4/20 0.57
SMN1; SMN2 Q16637 4/20 0.57
MEN1 O00255 5/20 0.57
KMT2A Q03164 5/20 0.57
PKM P14618 4/20 0.57
NFKB1 P19838 1/20 0.56
NFKB2 Q00653 1/20 0.56
RELA Q04206 1/20 0.56
ALDH1A1 P00352 5/20 0.56
HTT P42858 1/20 0.56
GAA P10253 1/20 0.56
HSP90AA1 P07900 1/20 0.55
SNCA P37840 1/20 0.55
KDM4E B2RXH2 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8899001 0.88 TP53 (0.60) CXCR2TP53TSHRCXCR1MAPT
SCHEMBL1463448 0.86 MAPT (0.71) TP53TSHRMAPTRAB9ANPC1
SCHEMBL6760907 0.85 DDX3X (0.59) TP53TSHRMAPTRAB9ANPC1
SCHEMBL6765010 0.85 MEN1 (0.60) TP53TSHRMAPTRAB9ANPC1
SCHEMBL6763521 0.85 FADS1 (0.64) TP53TSHRMAPTRAB9ANPC1
SCHEMBL6760893 0.85 ALDH1A1 (0.60) TP53TSHRMAPTRAB9ANPC1
SCHEMBL6763526 0.85 MAPT (0.77) TP53TSHRMAPTRAB9ANPC1
SCHEMBL4356025 0.85 TRPV1 (0.70) TP53TSHRMAPTRAB9ANPC1
SCHEMBL7594786 0.84 HDAC3 (0.61) TP53TSHRMAPTRAB9ANPC1
SCHEMBL6767742 0.84 MAPT (0.64) TP53TSHRMAPTRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040063742-A1 Treatment of parkinson's disease by the combined action of a compound with neurotrophic activity and a compound enhancing the dopamine activity NEUROSEARCH A/S (DK) 2004-04-01 US claimed
US-20040063742-A1 Treatment of parkinson's disease by the combined action of a compound with neurotrophic activity and a compound enhancing the dopamine activity NEUROSEARCH A/S (DK) 2004-04-01 US disclosed